Interleukin-1 receptor antagonism

Seminars in Nephrology

Volumn 16, Issue 6, 1996, Pages 583-590

  Nikolic Paterson, David J ^a   Lan, Hui Y ^a   Atkins, Robert C ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PREDNISOLONE;

AMINO ACID SEQUENCE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; GENE EXPRESSION; GENE THERAPY; GLOMERULONEPHRITIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; KIDNEY INJURY; MULTIGENE FAMILY; NEPHRITIS; NONHUMAN; PATHOGENESIS; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SEQUENCE HOMOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS;

EID: 0029854411     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Dinarello CA. Interleukin-l and interleukin-1 antagonism. Blood 77:1627-1652, 1991
2. Arend WP. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest 88:1445-1451, 1991
3. Mosley B, Urdal DL, Prickelt KS, et al. The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. J Biol Chem 262:2941-2944, 1987
4. Miller DK, Calaycay JR, Chapman KT, et al. The IL-1 beta converting enzyme as a therapeutic target. Ann N Y Acad Sci 696:133-148, 1993
5. Dripps DJ, Brandhuber BJ, Thompson RC, et al. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 266:10331-10336, 1991
6. Muzio M, Polentarutti N, Sironi M, et al. Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist. J Exp Med 182:623-628, 1995
7. Haskill S, Martin G, Van Le L, et al. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc Natl Acad Sci U S A 88:3681-3685, 1991
8. Watson JM, Lofquist AK, Rinehart CA, et al. The intracellular IL-1 receptor antagonist alters IL-1-inducible gene expression without blocking exogenous signaling by IL-1 beta. J Immunol 155:4467-4475, 1995
9. Bazan JF, Timans JC, Kastelein RA. A newly defined interleukin-1? Nature 379:5911996
10. Sims JE, March CJ, Cosman D, et al. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241:585-589, 1988
11. McMahan CJ, Slack JL, Mosley B, et al. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 10:2821-2832, 1991
12. Colotta F, Dower SK, Sims JE, et al. The type II 'decoy' receptor: A novel regulatory pathway for interleukin 1. Immunol Today 15:562-566, 1994
13. Stewart RJ, Marsden PA. Biologic control of the tumor necrosis factor and interleukin-1 signaling cascade. Am J Kidney Dis 25:954-966, 1995
14. Grilli M, Chiu JJ, Lenardo MJ. NF-kappa B and Rel: Participants in a multiform transcriptional regulatory system. Int Rev Cytol 143:1-62, 1993
15. Cao Z, Henzel WJ, Gao X. IRAK: A kinase associated with the interleukin-1 receptor. Science 271:1128-1131, 1996
16. Ferretti M, Casini-Raggi V, Pizarro TT, et al. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J Clin Invest 94:449-453, 1994
17. Muzio M, Sironi M, Polentarutti N, et al. Induction by transforming growth factor-beta 1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cells. Eur J Immunol 24:3194-3198, 1994
18. Makarov SS, Olsen JC, Johnston WN, et al. Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc Natl Acad Sci U S A 93:402-406, 1996
19. Matsumoto K, Dowling J, Atkins RC. Production of interleukin 1 in glomerular cell cultures from patients with rapidly progressive crescentic glomerulonephritis. Am J . Nephrol 8:463-470, 1988
20. Noronha IL, Kruger C, Andrassy K, et al. In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 43:682-692, 1993
21. Yoshioka K, Takemura T, Murakami K, et al. In situ expression of cytokines in IgA nephritis. Kidney Int 44:825-833, 1993
22. Jenkins DA, Wojtacha DR, Swan P, et al: Intrarenal localization of interleukin-1 beta mRNA in crescentic glomerulonephritis. Nephrol Dial Transplant 9:1228-1233, 1994
23. Rastaldi MP, Ferrario F, Tunesi S, et al. Intraglomerular and interstitial leukocyte infiltration, adhesion molecules, and interleukin-1 alpha expression in 15 cases of antineutrophil cytoplasmic autoantibody-associated renal vasculitis. Am J Kidney Dis 27:48-57, 1996
24. Nikolic-Paterson DJ, Main IW, Tesch G, et al. Interleukin-1 in renal fibrosis. Kidney Int 49:88-90, 1996 (suppl 54)
25. Atkins RC. Interleukin-1 in crescentic glomerulonephritis. Kidney Int 48:576-586, 1995
26. Tomosugi NI, Cashman SJ, Hay H, et al. Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1. J Immunol 142:3083-3090, 1989
27. Camussi G, Tetta C, Bussolino F, et al. Effect of leukocyte stimulation on rabbit immune complex glomerulonephritis. Kidney Int 38:1047-1055, 1990
28. Karkar AM, Koshino Y, Cashman SJ, et al. Passive immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats. Clin Exp Immunol 90:312-318, 1992
29. Karkar AM, Tarn FWK, Steinkasserer A, et al. Modulation of antibody-mediated glomerular injury in vivo by IL-Ira, soluble IL-1 receptor, and soluble TNF receptor. Kidney Int 48:1738-1746, 1995
30. Mulligan MS, Johnson KJ, Todd RF, 3d, et al: Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest 91:577-587, 1993
31. Tang WW, Feng L, Vannice JL, et al. Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis. J Clin Invest 93:273-279, 1994
32. Lan HY, Nikolic-Paterson DJ, Zarama M, et al. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int 43:479-485, 1993
33. Lan HY, Nikolic-Paterson DJ, Mu W, et al. Interleu-kin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat. Kidney Int 47:1303-1309, 1995
34. Martin A, Molina A, Bricio T, et al. Passive dual immunization against tumour necrosis factor-alpha (TNF-alpha) and IL-1 beta maximally ameliorates acute aminonucleoside nephrosis. Clin Exp Immunol 99:283-288, 1995
35. Tesch G, Nikolic-Paterson DJ, Lan HY, et al. IL-1 receptor antagonist inhibits mesangial cell proliferation in rat anti-Thy-1 nephritis. J Am Soc Nephrol 6:886, 1995 (abstr)
36. Lonnemann G, Shapiro L, Engler-Blum G, et al. Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney flbroblasts. Kidney Int 47:837-844, 1995
37. Bathon JM, Hwang JJ, Shin LH, et al. Type VI collagen-specific messenger RNA is expressed constitutively by cultured human synovial flbroblasts and is suppressed by interleukin-1. Arthritis Rheum 37:1350-1356, 1994
38. Auphan N, DiDonato JA, Rosette C, et al. Immunosuppression by glucqcorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286-290, 1995